ArticleMolecular oncology2018

Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.

Steven R Whittaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.